curATime is one of 7 future clusters in the second funding round of the ‘Clusters4Future’ initiative of the Federal Ministry of Education and Research. The aim of our cluster is to meet the challenge of customised treatments for atherothrombosis-related cardiovascular diseases with the help of complementary competencies of powerful players from science and industry. In addition, we want to identify molecularly defined precision interventions that reduce the incidence and impact of cardiovascular disease in the population and thus significantly reduce mortality.
Company Details
- Employees
- 6
- Address
- Mainz, 55131, De
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://curatime.org/
- Keywords
- Biomarkeridentifizierung, mRNA-Technologie, Künstliche Intelligenz, Populations- und Patientenkohorten, krankheitsassoziierte Risikoprofile.
- HQ
- Mainz
Curatime Cluster For Future Questions
Curatime Cluster For Future's website is https://curatime.org/
Curatime Cluster For Future's LinkedIn profile is https://de.linkedin.com/company/curatime
Curatime Cluster For Future has
6 employees.
View email and phone details for 6
employees at Curatime Cluster For Future.
Curatime Cluster For Future's industry is
Biotechnology Research
Curatime Cluster For Future's top competitors are
Actitrexx Gmbh,
Tetraneuron,
Biontech Se,
M-Lab Gmbh,
Xyna.bio,
Mainz Biomed,
Heidelberg Pharma Ag,
Tron-Mainz,
Life Science Zentrum Mainz,
Biomindz.
Curatime Cluster For Future's categories are Biotechnology Research
